Jeremy R Ellis

Dr. Jeremy R Ellis

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
JEJeremy R Ellis
Jeremy R Ellis
EPEron Justin Powell
Eron Justin Powell
LTLuke Tomasovic
Luke Tomasovic
RMRachel Marcheskie
Rachel Marcheskie
VGVishruth Girish
Vishruth Girish
DSDarshan Sivaloganathan
Darshan Sivaloganathan
The skin microbiome consists of bacteria, fungi, viruses, and mites, which play a crucial role in maintaining skin health and immune function. Imbalances in this microbial community, known as dysbiosis, are implicated in various dermatological conditions. While skincare products are known to influence the skin microbiome, the effects of dermatological procedures have not been extensively studied. Here, we perform a scoping review to outline the studies investigating the impacts of dermatological interventions on the skin microbiome. Phototherapy emerged as the most studied intervention, encompassing UV phototherapy, light therapy, laser therapy, and photodynamic therapy. Chemical interventions, such as chemical peels, micropigmentation, and debridement, have comparatively limited studies describing their impacts on the skin microbiome. To date, no studies have been done on a wide variety of common dermatological procedures such as cryotherapy, skin grafts, and dermabrasion, which may have stronger likelihoods of affecting the skin microbiome. This underscores the need for further research on the influences of dermatological procedures, especially chemical and physical interventions, on the skin microbiome. More comprehensive pre-clinical and clinical studies are essential not only for understanding the long-term consequences of these procedures, but also for optimizing patient outcomes in dermatological care.

23 January 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
JEJeremy R Ellis
Jeremy R Ellis
JBJames Bull
James Bull
PRPaul Rowley
Paul Rowley
Commercially available cellulases and amylases can disperse the pathogenic bacteria embedded in biofilms. This suggests that polysaccharide-degrading enzymes would be useful as antibacterial therapies to aid the treatment of biofilm-associated bacteria, e.g., in chronic wounds. Using a published enzyme library, we explored the capacity of 76 diverse recombinant glycoside hydrolases to disperse Staphylococcus aureus biofilms. Four of the 76 recombinant glycoside hydrolases digested purified cellulose, amylose, or pectin. However, these enzymes did not disperse biofilms, indicating that anti-biofilm activity is not general to all glycoside hydrolases and that biofilm activity cannot be predicted from the activity on pure substrates. Only one of the 76 recombinant enzymes was detectably active in biofilm dispersion, an α-xylosidase from Aspergillus nidulans. An α-xylosidase cloned subsequently from Aspergillus thermomutatus likewise demonstrated antibiofilm activity, suggesting that α-xylosidases, in general, can disperse Staphylococcus biofilms. Surprisingly, neither of the two β-xylosidases in the library degraded biofilms. Commercial preparations of amylase and cellulase that are known to be effective in the dispersion of Staphylococcus biofilms were also analyzed. The commercial cellulase contained contaminating proteins with multiple enzymes exhibiting biofilm-dispersing activity. Successfully prospecting for additional antibiofilm enzymes may thus require large libraries and may benefit from purified enzymes. The complexity of biofilms and the diversity of glycoside hydrolases continue to make it difficult to predict or understand the enzymes that could have future therapeutic applications.

2 September 2008 in Optics Express
Verified
Journal Article
Open access
PDF file
JBJohn Broky
John Broky
JEJeremy R Ellis
Jeremy R Ellis
ADAristide Dogariu
Aristide Dogariu
We demonstrate that spatial non-stationarities can be identified from one realization of wave interaction with a random medium. Fourth-order correlations between field components at two different spatial points are shown to provide the necessary information.

9 June 2025 in Laboratory Investigation
Verified
Journal Article
Closed access
JEJeremy R Ellis
Jeremy R Ellis
EWElizabeth Will
Elizabeth Will
AOAleksandra Ogurtsova
Aleksandra Ogurtsova
LELogan L. Engle
Logan L. Engle
JTJanis M. Taube
Janis M. Taube
JSJoel C Sunshine
Joel C Sunshine

18 July 2025 in Journal of Liver Transplantation
Verified
Journal Article
Open access
LTLuke Tomasovic
Luke Tomasovic
JEJeremy R Ellis
Jeremy R Ellis
ASAlexander C. Schulick
Alexander C. Schulick
PAParth Agrawal
Parth Agrawal
AWAnmol Warman
Anmol Warman
EKElizabeth A. King
Elizabeth A. King
Alcohol-related liver disease (ARLD) represents a major cause of end-stage liver disease and has surged as a leading indication for liver transplantation. This study investigates geographic disparities in liver transplant center availability relative to the regional burdens of ARLD mortality and alcohol use disorder (AUD) prevalence in the U.S. Using state-level data from publicly available databases, we evaluated the relationships between liver transplant center density, ARLD mortality, and AUD prevalence. We also developed two novel metrics: the AUD prevalence-to-transplant recipients (AUDT) ratio and the ARLD deaths-to-transplant recipients (ARLDT) ratio. These ratios served as proxies for assessing disparities between the need for and access to liver transplant services. Our findings reveal that while AUD prevalence and AUDT ratios did not significantly vary with transplant center density, higher ARLD mortality per capita and ARLDT ratios were correlated with lower transplant center density. States without a transplant center also experienced significantly higher ARLD mortality per capita compared to states with at least one transplant center per 100,000 square miles. These findings underscore the significant role of geographic factors in accessing transplant care and suggest that barriers to transplant centers may contribute to outcome disparities among patients with ARLD. The study also highlights the need for targeted healthcare planning and policy interventions to enhance liver transplant access, particularly in regions with disproportionately high ARLD burdens and limited transplant infrastructure. Future research should utilize more granular geographies, such as transplant referral regions, and incorporate covariates related to overall healthcare infrastructure and access.

28 March 2025 in Transformative Medicine
Verified
Journal Article
Open access
PDF file
JEJeremy R Ellis
Jeremy R Ellis
LTLuke Tomasovic
Luke Tomasovic
RMRachel Marcheskie
Rachel Marcheskie
By Jeremy R. Ellis, Luke M. Tomasovic, and Rachel L. Marcheskie, Published on 03/28/25